GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

Go back to GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
(NASDAQ: WGS) Delayed: 101.10 -3.85 (3.67%)
Previous Close $104.95    52 Week High
Open $104.59    52 Week Low
Day High $105.00    P/E N/A 
Day Low $99.70    EPS
Volume 786,132